{"Abstract": [0], "SARS-CoV-2": [1, 190], "Omicron": [2, 65, 187], "subvariants": [3, 25, 196], "BA.2.12.1": [4, 67, 108, 183], "and": [5, 17, 50, 78, 90, 109, 122, 143, 163, 184], "BA.4/5": [6, 84, 110, 136], "have": [7], "surged": [8], "notably": [9], "to": [10, 74, 94, 96, 117, 192, 207], "become": [11], "dominant": [12], "in": [13, 29, 106, 135], "the": [14, 45, 118, 126, 148, 152, 165], "United": [15], "States": [16], "South": [18], "Africa,": [19], "respectively": [20], "1,2": [21], ".": [22, 130], "These": [23], "new": [24], "carrying": [26], "further": [27, 38, 43], "mutations": [28], "their": [30], "spike": [31, 102, 149], "proteins": [32], "raise": [33], "concerns": [34], "that": [35, 197], "they": [36], "may": [37], "evade": [39], "neutralizing": [40], "antibodies,": [41], "thereby": [42], "compromising": [44], "efficacy": [46], "of": [47, 62, 125, 167, 189], "COVID-19": [48], "vaccines": [49], "therapeutic": [51, 170], "monoclonals.": [52], "We": [53], "now": [54], "report": [55], "findings": [56], "from": [57, 76, 113, 139], "a": [58], "systematic": [59], "antigenic": [60], "analysis": [61], "these": [63], "surging": [64], "subvariants.": [66], "is": [68, 85], "only": [69, 176, 200], "modestly": [70], "(1.8-fold)": [71], "more": [72, 88, 92, 201, 205], "resistant": [73, 89], "sera": [75], "vaccinated": [77], "boosted": [79], "individuals": [80], "than": [81], "BA.2.": [82], "However,": [83], "substantially": [86], "(4.2-fold)": [87], "thus": [91], "likely": [93], "lead": [95], "vaccine": [97], "breakthrough": [98], "infections.": [99], "Mutation": [100], "at": [101], "residue": [103], "L452": [104], "found": [105, 134], "both": [107, 182], "facilitates": [111, 137], "escape": [112, 138], "some": [114], "antibodies": [115, 145, 171], "directed": [116], "so-called": [119], "class": [120, 141], "2": [121, 144], "3": [123, 129], "regions": [124], "receptor-binding": [127], "domain": [128], "The": [131, 155, 186], "F486V": [132], "mutation": [133], "certain": [140], "1": [142], "but": [146, 203], "compromises": [147], "affinity": [150, 162], "for": [151, 173], "viral": [153], "receptor.": [154], "R493Q": [156], "reversion": [157], "mutation,": [158], "however,": [159], "restores": [160], "receptor": [161], "consequently": [164], "fitness": [166], "BA.4/5.": [168, 185], "Among": [169], "authorized": [172], "clinical": [174], "use,": [175], "bebtelovimab": [177], "retains": [178], "full": [179], "potency": [180], "against": [181], "lineage": [188], "continues": [191], "evolve,": [193], "successively": [194], "yielding": [195], "are": [198], "not": [199], "transmissible": [202], "also": [204], "evasive": [206], "antibodies.": [208]}